PDCD1 and non-small cell lung carcinoma: Based on available data, it can be assumed with a high probability that NSCLC patients with rs4143815 CC genotype will have elevated PD-L1 expression in tumour tissue, indicating better responses to mAbs blocking the interaction between PD-1 and PD-L1 (Nomizo et al. 2017).